Antibodies to neurofilaments

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Immune responses targeting neuronal proteins are common in neurodegenerative diseases.
• Neurofilament (NF) proteins are crucial components of neuronal structure.
• Autoantibodies to neurofilaments may play a role in neurodegeneration.

Purpose of the Study:

• To investigate autoantibodies against three neurofilament (NF) subunits (NF-L, NF-M, NF-H) in Down syndrome (DS).
• To examine the association of these antibodies with phosphorylated and dephosphorylated forms.
• To correlate antibody levels with age, human leukocyte antigen (HLA) status, and disease severity in DS.

Main Methods:

• Immunoblot analysis was used to detect IgG antibodies against NF-L, NF-M, and NF-H in both phosphorylated and dephosphorylated forms.
• 128 patients with DS and 94 healthy controls were included in the study.
• DS diagnosis was confirmed by karyotype analysis.

Main Results:

• Antibodies to dephosphorylated NF-M, NF-M, and NF-L were more prevalent in DS patients compared to controls.
• While overall NF-H antibody frequency was similar, DS patients with mild/moderate disability showed higher prevalence (43.0%) than those with severe disability (14.3%).
• No NF-H antibodies were detected in young children (≤14 years) with severe disability; HLA-DR15 allele showed a negative correlation with NF-H antibodies.

Conclusions:

• The elevated prevalence of neurofilament autoantibodies in DS suggests a complex interplay between neural and immune systems.
• These antibodies might be involved in protecting neural structures from neurodegenerative processes.
• In pediatric DS, the presence of NF-H antibodies could be a marker for a more favorable clinical outcome.